Model systems and unique biological features of high and low-grade colorectal cancer (CRC) revealed by xenografting 84 human CRC cell lines
- Ian Y Luk 1,2, Jennifer K Mooi 1,3, Dmitri Mouradov 4,5, Tao Tan 4,5, Cameron M Scott 1, Fiona Chionh 1,2, Laura J Jenkins 1,2, Camilla M Reehorst 1,2, Rebecca Nightingale 1,2, Peter Savas 6, Janson Wt Tse 1,2, Rebekah Li Crake 1,2, Eduard Batlle 7,8,9, Diego Arango 10, Higino Dopeso 11, Peter Gibbs 4, Niall C Tebbutt 1,2,12, Rod B Luwor 12, Andrew M Scott 1,2,3, Faiza Basheer 13, Amardeep S Dhillon 13, Nicholas J Clemons 6, David S Williams 1,2,14, Ron Firestein 15, Oliver M Sieber 16,17,18,19, John M Mariadason 20,21,22
- Ian Y Luk 1,2, Jennifer K Mooi 1,3, Dmitri Mouradov 4,5
- 1Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.
- 2La Trobe University School of Cancer Medicine, Melbourne, Victoria, Australia.
- 3Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
- 4Walter and Eliza Hall Institute, Melbourne, Victoria, Australia.
- 5Department of Medical Biology, The University of Melbourne, Parkville, VIC 3052, Australia.
- 6Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
- 7Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
- 8Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.
- 9Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
- 10Biomedical Research Institute of Lleida, IRBLleida, Lleida, Spain.
- 11Memorial Sloan-Kettering, New York, NY, USA.
- 12Department of Surgery, University of Melbourne, Parkville, Victoria, Australia.
- 13Institute of Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Waurn Ponds, Victoria, Australia.
- 14Department of Pathology, Austin Health, Melbourne, Victoria, Australia.
- 15Centre for Cancer Research, Hudson Institute for Medical Research, Monash University, Melbourne, Victoria, Australia.
- 16Walter and Eliza Hall Institute, Melbourne, Victoria, Australia. sieber.o@wehi.edu.au.
- 17Department of Medical Biology, The University of Melbourne, Parkville, VIC 3052, Australia. sieber.o@wehi.edu.au.
- 18Department of Surgery, University of Melbourne, Parkville, Victoria, Australia. sieber.o@wehi.edu.au.
- 19Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia. sieber.o@wehi.edu.au.
- 20Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia. john.mariadason@onjcri.org.au.
- 21La Trobe University School of Cancer Medicine, Melbourne, Victoria, Australia. john.mariadason@onjcri.org.au.
- 22Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia. john.mariadason@onjcri.org.au.
- 0Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.High-grade colorectal cancers (CRCs) show suppressed differentiation and stem cell markers, alongside increased proliferation and metastasis. These findings in cell line models accurately reflect patient tumors, offering new avenues for CRC treatment strategies.
Area Of Science
- Oncology
- Molecular Biology
- Cancer Research
Background
- Colorectal cancers (CRCs) exhibit varying differentiation grades impacting patient outcomes.
- The molecular drivers of CRC differentiation status remain incompletely understood.
Purpose Of The Study
- To investigate the molecular features and drivers of low-grade (LG) versus high-grade (HG) colorectal cancers.
- To establish and validate cell line-derived xenograft models for studying CRC differentiation.
Main Methods
- Xenografting of 84 human CRC cell lines in mice to create LG and HG models.
- Transcriptional profiling to analyze gene expression differences between LG and HG tumors.
- Analysis of promoter methylation and stem cell marker expression.
Main Results
- HG tumors showed downregulation of differentiation factors and colonic lineage markers.
- Epigenetic silencing via promoter methylation was observed in HG tumors.
- HG tumors exhibited increased proliferation, migration, and metastatic capacity, with altered stem cell marker expression.
Conclusions
- CRC cell lines accurately model tumor differentiation grade, as validated in patient-derived organoids and primary CRCs.
- Identified molecular properties of HG CRCs may guide the development of grade-specific therapeutic strategies.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

